BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 6822241)

  • 1. Urine composition following jejunoileal bypass.
    Nordenvall B; Backman L; Larsson L; Tiselius HG
    Eur Urol; 1983; 9(1):35-9. PubMed ID: 6822241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of calcium treatment on urinary stone index after intestinal bypass for obesity.
    Holm CN; Hessov I
    Digestion; 1981; 22(5):255-8. PubMed ID: 7308596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of calcium, aluminium, magnesium and cholestyramine on hyperoxaluria in patients with jejunoileal bypass.
    Nordenvall B; Backman L; Larsson L; Tiselius HG
    Acta Chir Scand; 1983; 149(1):93-8. PubMed ID: 6837229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A biochemical basis for grouping of patients with urolithiasis.
    Tiselius HG; Almgård LE; Larsson L; Sörbo B
    Eur Urol; 1978; 4(4):241-9. PubMed ID: 668734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical risk factors for stone formation in a Scottish paediatric hospital population.
    MacDougall L; Taheri S; Crofton P
    Ann Clin Biochem; 2010 Mar; 47(Pt 2):125-30. PubMed ID: 20144971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical studies on the recurrence of urolithiasis: (1). Influence of diet on urinary excretion of the stone forming constituents].
    Murayama T; Taguchi H
    Hinyokika Kiyo; 1987 Sep; 33(9):1321-30. PubMed ID: 3434487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of different diets on urine composition and the risk of calcium oxalate crystallisation in healthy subjects.
    Siener R; Hesse A
    Eur Urol; 2002 Sep; 42(3):289-96. PubMed ID: 12234515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urine composition in patients with renal stone disease during treatment with allopurinol.
    Tiselius HG; Larsson L
    Scand J Urol Nephrol; 1980; 14(1):65-71. PubMed ID: 7375845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of overweight and obesity in calcium oxalate stone formation.
    Siener R; Glatz S; Nicolay C; Hesse A
    Obes Res; 2004 Jan; 12(1):106-13. PubMed ID: 14742848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A study on the cause of urolithiasis of the upper urinary tract--clinical study of risk factors in the formation of stones in the upper urinary tract].
    Nonomura M; Kawamura J; Ueda M; Okada Y; Takeuchi H; Yoshida O
    Hinyokika Kiyo; 1986 Mar; 32(3):311-25. PubMed ID: 3728237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary saturation and risk factors for calcium oxalate stone disease based on spot and 24-hour urine specimens.
    Ogawa Y; Yonou H; Hokama S; Oda M; Morozumi M; Sugaya K
    Front Biosci; 2003 Sep; 8():a167-76. PubMed ID: 12957883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in urinary composition of calcium oxalate stone formers.
    Rahman B; Rahman MA
    Biomed Pharmacother; 1986; 40(3):108-10. PubMed ID: 3742009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [14C]Oxalate absorption by normal persons, calcium oxalate stone formers, and patients with surgically disturbed intestinal function.
    Tiselius HG; Ahlstrand C; Lundström B; Nilsson MA
    Clin Chem; 1981 Oct; 27(10):1682-5. PubMed ID: 7285319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcium treatment of enteric hyperoxaluria after jejunoileal bypass for morbid obesity.
    Hylander E; Jarnum S; Nielsen K
    Scand J Gastroenterol; 1980; 15(3):349-52. PubMed ID: 7433895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Estimation of 24-h excretion of some promotors and inhibitors of crystallization and degree of urine saturation with calcium oxalate in calcium urinary calculi].
    Boruczkowska A
    Pol Arch Med Wewn; 1994 Oct; 92(4):289-98. PubMed ID: 7854956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of overweight and obesity on the urinary excretion of promoters and inhibitors of stone formation in stone formers.
    Negri AL; Spivacow FR; Del Valle EE; Forrester M; Rosende G; Pinduli I
    Urol Res; 2008 Dec; 36(6):303-7. PubMed ID: 18985334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary excretion of calcium, magnesium, oxalate and citrate in duodenal ulcer patients. Preliminary results before and up to five years after highly selective vagotomy.
    Schwille PO; Scholz D; Hanisch E; Zeuner E; Schwendtner H; Husemann B; Mühe E; Sigel A
    Klin Wochenschr; 1983 Sep; 61(17):845-50. PubMed ID: 6632726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urine composition in patients with urolithiasis during treatment with magnesium oxide.
    Tiselius HG; Ahlstrand C; Larsson L
    Urol Res; 1980; 8(4):197-206. PubMed ID: 7222314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of urinary oxalate excretion in urolithiasis patients with and without hypercalciuria.
    Koide T; Bowyer RC; Brockis JG
    Br J Urol; 1985 Oct; 57(5):505-9. PubMed ID: 4063729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of cocoa on excretion of oxalate, citrate, magnesium and calcium in the urine of children].
    Lagemann M; Anders D; Graef V; Bödeker RH
    Monatsschr Kinderheilkd; 1985 Oct; 133(10):754-9. PubMed ID: 4069117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.